Patients with high CD74 gene expression and protein expression (ICP ≥ 10%) effective clinical response and prolonged survival following AK104 treatment, suggesting that CD74 has potential predictive performance in AK104 cancer therapy. The gene discussed is CD74; the disease is cancer.